ATE448778T1 - Muscarin-agonisten zur behandlung von impulskontrollstörungen - Google Patents
Muscarin-agonisten zur behandlung von impulskontrollstörungenInfo
- Publication number
- ATE448778T1 ATE448778T1 AT07728391T AT07728391T ATE448778T1 AT E448778 T1 ATE448778 T1 AT E448778T1 AT 07728391 T AT07728391 T AT 07728391T AT 07728391 T AT07728391 T AT 07728391T AT E448778 T1 ATE448778 T1 AT E448778T1
- Authority
- AT
- Austria
- Prior art keywords
- impulse control
- control disorders
- disorder
- agonists
- treatment
- Prior art date
Links
- 208000026331 Disruptive, Impulse Control, and Conduct disease Diseases 0.000 title abstract 6
- 208000030990 Impulse-control disease Diseases 0.000 title abstract 4
- 239000000556 agonist Substances 0.000 title abstract 2
- UQOFGTXDASPNLL-XHNCKOQMSA-N Muscarine Chemical compound C[C@@H]1O[C@H](C[N+](C)(C)C)C[C@H]1O UQOFGTXDASPNLL-XHNCKOQMSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 2
- 206010071238 Binge Drinking Diseases 0.000 abstract 1
- 206010004716 Binge eating Diseases 0.000 abstract 1
- 208000032841 Bulimia Diseases 0.000 abstract 1
- 206010012335 Dependence Diseases 0.000 abstract 1
- 208000001836 Firesetting Behavior Diseases 0.000 abstract 1
- 206010017389 Frotteurism Diseases 0.000 abstract 1
- 208000001613 Gambling Diseases 0.000 abstract 1
- 206010019191 Head banging Diseases 0.000 abstract 1
- 206010026864 Masochism Diseases 0.000 abstract 1
- 206010057342 Onychophagia Diseases 0.000 abstract 1
- 206010034158 Pathological gambling Diseases 0.000 abstract 1
- 208000032769 Pedophilia Diseases 0.000 abstract 1
- 208000033712 Self injurious behaviour Diseases 0.000 abstract 1
- 208000014679 binge eating disease Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 208000003481 exhibitionism Diseases 0.000 abstract 1
- 206010016531 fetishism Diseases 0.000 abstract 1
- 208000015046 intermittent explosive disease Diseases 0.000 abstract 1
- 206010023461 kleptomania Diseases 0.000 abstract 1
- 230000003551 muscarinic effect Effects 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 201000004645 pyromania Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000001568 sexual effect Effects 0.000 abstract 1
- 208000013623 stereotypic movement disease Diseases 0.000 abstract 1
- 201000005142 transvestism Diseases 0.000 abstract 1
- 208000002271 trichotillomania Diseases 0.000 abstract 1
- 208000008918 voyeurism Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US79735506P | 2006-05-04 | 2006-05-04 | |
| EP06113476 | 2006-05-04 | ||
| PCT/EP2007/053934 WO2007128674A2 (en) | 2006-05-04 | 2007-04-23 | Muscarinic agonists to treat impulse control disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE448778T1 true ATE448778T1 (de) | 2009-12-15 |
Family
ID=38544084
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07728391T ATE448778T1 (de) | 2006-05-04 | 2007-04-23 | Muscarin-agonisten zur behandlung von impulskontrollstörungen |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP2023909B1 (de) |
| JP (1) | JP2010501471A (de) |
| KR (1) | KR20090013815A (de) |
| AT (1) | ATE448778T1 (de) |
| AU (1) | AU2007247231B2 (de) |
| CA (1) | CA2649917A1 (de) |
| DE (1) | DE602007003348D1 (de) |
| EA (1) | EA014915B1 (de) |
| ES (1) | ES2336275T3 (de) |
| IL (1) | IL194778A0 (de) |
| PL (1) | PL2023909T3 (de) |
| WO (1) | WO2007128674A2 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110294835A1 (en) * | 2008-05-15 | 2011-12-01 | The Board Of Trustees Of The University Of Illinois | Muscarinic Agonists as Cognitive Enhancers |
| HUE044653T2 (hu) | 2009-07-22 | 2019-11-28 | PureTech Health LLC | Készítmények olyan rendellenességek kezelésére, amelyek muszkarin-receptor aktiválással enyhíthetõk |
| US10265311B2 (en) | 2009-07-22 | 2019-04-23 | PureTech Health LLC | Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation |
| KR101613245B1 (ko) | 2015-04-27 | 2016-04-18 | 주식회사 대웅제약 | 신규의 4-메톡시 피롤 유도체 또는 이의 염 및 이를 포함하는 약학 조성물 |
| BR112021005802B1 (pt) | 2018-09-28 | 2022-02-15 | Karuna Therapeutics, Inc | Composição farmacêutica oral |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE922270A1 (en) * | 1991-07-26 | 1993-01-27 | Akzo Nv | Pyrazole derivatives |
| US6117890A (en) * | 1996-08-01 | 2000-09-12 | Eli Lilly And Company | Method for treating bipolar disorder |
| WO2002067931A1 (en) * | 2001-02-23 | 2002-09-06 | Johns Hopkins University | Treatment of tics, tremors and related disorders |
| WO2006017614A1 (en) * | 2004-08-05 | 2006-02-16 | Acadia Pharmaceuticals Inc. | Use of n-desmethylclozapine to treat human neuropsychiatric disease |
| TW200528455A (en) * | 2003-12-19 | 2005-09-01 | Bristol Myers Squibb Co | Azabicyclic heterocycles as cannabinoid receptor modulators |
| GB0428170D0 (en) * | 2004-12-23 | 2005-01-26 | Biopartners Ltd | Mono and Combination Therapy |
-
2007
- 2007-04-23 AT AT07728391T patent/ATE448778T1/de not_active IP Right Cessation
- 2007-04-23 PL PL07728391T patent/PL2023909T3/pl unknown
- 2007-04-23 CA CA002649917A patent/CA2649917A1/en not_active Abandoned
- 2007-04-23 EA EA200870498A patent/EA014915B1/ru not_active IP Right Cessation
- 2007-04-23 WO PCT/EP2007/053934 patent/WO2007128674A2/en not_active Ceased
- 2007-04-23 ES ES07728391T patent/ES2336275T3/es active Active
- 2007-04-23 DE DE602007003348T patent/DE602007003348D1/de active Active
- 2007-04-23 KR KR1020087029621A patent/KR20090013815A/ko not_active Withdrawn
- 2007-04-23 EP EP07728391A patent/EP2023909B1/de not_active Not-in-force
- 2007-04-23 JP JP2009508308A patent/JP2010501471A/ja active Pending
- 2007-04-23 AU AU2007247231A patent/AU2007247231B2/en not_active Expired - Fee Related
-
2008
- 2008-10-22 IL IL194778A patent/IL194778A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA200870498A1 (ru) | 2009-04-28 |
| EP2023909B1 (de) | 2009-11-18 |
| WO2007128674A2 (en) | 2007-11-15 |
| DE602007003348D1 (de) | 2009-12-31 |
| JP2010501471A (ja) | 2010-01-21 |
| PL2023909T3 (pl) | 2010-04-30 |
| IL194778A0 (en) | 2009-08-03 |
| AU2007247231A1 (en) | 2007-11-15 |
| CA2649917A1 (en) | 2007-11-15 |
| AU2007247231B2 (en) | 2012-05-31 |
| EP2023909A2 (de) | 2009-02-18 |
| WO2007128674A3 (en) | 2008-04-03 |
| KR20090013815A (ko) | 2009-02-05 |
| ES2336275T3 (es) | 2010-04-09 |
| EA014915B1 (ru) | 2011-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE448778T1 (de) | Muscarin-agonisten zur behandlung von impulskontrollstörungen | |
| SI1425277T1 (sl) | Seäśninske spojine, aktivne kot vaniloidni receptorski antagonisti za zdravljenje boleäśine | |
| IL197118A0 (en) | Ultrasonic treatment of glaucoma | |
| WO2010030813A3 (en) | Methods for inhibiting ocular angiogenesis | |
| WO2010042163A3 (en) | Quinoline compounds as inhibitors of angiogenesis, human methionine aminopeptidase, and sirt1, and methods of treating disorders | |
| WO2008095086A3 (en) | Topiramate plus naltrexone for the treatment of addictive disorders | |
| EP2397159A3 (de) | Kombination von Morphinan-Verbindungen und Antidepressiva zur Behandlung von hartnäckigen und chronischen Schmerzen | |
| WO2008036678A3 (en) | Combination comprising a peroxisome proliferator activated receptor agent and a second neurogenic agent for treating a nervous system disorder, increasing neurodifferentiation and increasing neurogenesis | |
| MX2007005205A (es) | Compuestos biciclicos sulfonilo-sustituidos como moduladores de receptores activados por el proliferador de la peroxisoma. | |
| ATE360633T1 (de) | N-substituierte hydromorphone und ihre anwendung | |
| SI2024368T1 (sl) | Derivati 6,7,8,9-tetrahidro-5h-pirimido(4,5-d)azepin-4-il)-amina kot modulatorji trpv 1 za zdravljenje boleäśine | |
| FI20041152L (fi) | Kemiallisen massan ksylanaasikäsittely | |
| FR2927330B1 (fr) | Derives de 5,6-bisaryl-2-pyridine-carboxamide, leur preparation et leur application en therapeutique comme antagonistes des recepteurs a l'urotensine ii | |
| WO2007003411A3 (en) | Kinin antagonists for treating bladder dysfunction | |
| WO2004084943A8 (en) | Use of antagonists of ghrelin or ghrelin receptor to treat intestinal inflammation | |
| NZ595545A (en) | Compositions and methods for prophylaxis and treatment of addictions | |
| CA2474510A1 (en) | Fused tricyclic heterocycles useful for treating hyper-proliferative disorders | |
| EP1919480A4 (de) | Hedgehog-weg-antagonisten zur behandlung von krankheiten | |
| EP2364705A3 (de) | Modulatoren von muskarinischen Rezeptoren | |
| TN2009000014A1 (en) | Novel chromene and thiochromene carboxamide derivatives, methods for preparing same and therapeutic applications of same | |
| DE602004025508D1 (de) | Modulatoren von peripheren 5-ht-rezeptoren | |
| RU2011103475A (ru) | Новая возможность борьбы с гиардиазом | |
| EP1749000A4 (de) | Bicyclische substituierte triazole als ppar-modulatoren und verfahren zu deren herstellung | |
| DE60127712D1 (de) | Selektive dopamin-d4-rezeptoragonisten zur behandlung von sexuellen dysfunktionen | |
| AR060722A1 (es) | Agonistas muscarinicos para tratar trastornos de control de impulsos. uso |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |